BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  10x Genomics Announces New Partnership Programs

  10x Genomic today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics’ sequencing applications through the Certified Service Provider and 10x Compatible Programs.

  February 12, 2018

   · 

  3 min read
• Biotech Bay

  Aimmune Therapeutics Announces Presentations at 2018 AAAAI-WAO Joint Congress

  Aimmune Therapeutics today announced that it will present data during a late-breaking oral abstract session and in poster sessions at the 2018 American Academy of Allergy, Asthma & Immunology–World Allergy Organization Joint Congress, taking place March 2–5 in Orlando.

  February 12, 2018

   · 

  4 min read
• Business

  Advanced Accelerator Applications Signs Exclusive License Agreement With Cancer Targeted Technology to Develop CTT1057, an F-18 Labeled PSMA Ligand for Diagnostic Applications in Prostate Cancer

  The terms of the agreement include an upfront licensing fee, as well as certain milestone and royalty payments.

  February 12, 2018

   · 

  5 min read
• Deals

  Avadel Pharmaceuticals Announces Divestiture of Pediatric Business

  The Company expects the deal to be accretive to EPS in 2018.

  February 12, 2018

   · 

  4 min read
• Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons on 10 February 2018

  The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

  February 12, 2018

   · 

  1 min read
• Novo Nordisk A/S: Share Repurchase Programme – Feb. 12, 2018

  This programme is part of the overall share repurchase programme of up to DKK 14 billion to be executed during a 12-month period beginning 1 February 2018.

  February 12, 2018

   · 

  1 min read
• Business

  Bioventus to Continue Distributing SUPARTZ FX Through 2028

  Under terms of this new agreement, Bioventus will be the exclusive distributor of SUPARTZ FX in the US through May 2028.

  February 12, 2018

   · 

  2 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center: Experimental Therapy Restores Nerve Insulation Damaged by Disease

  When the body attacks its own healthy tissues in an autoimmune disease, peripheral nerve damage handicaps people and causes persistent neuropathic pain when insulation on healing nerves doesn’t fully regenerate.

  February 12, 2018

   · 

  3 min read
• Innovative Medical Devices for the Treatment of Diabetes, Defymed Strengthens Its Position as a Worldwide Leader

  As part of this approach, two innovative medical devices, ExOlin® and MailPan®, have been developed by Defymed to provide patients with a more physiological treatment.

  February 12, 2018

   · 

  2 min read
• Business

  Daré Bioscience Enters into License and Collaboration Agreement for a Product with the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder

  FSAD is characterized primarily by an inability to attain or maintain sufficient physical sexual arousal that causes distress or interpersonal difficulty.

  February 12, 2018

   · 

  5 min read